← Evidence map

ReviewGene therapy2024

AAV gene therapy for Duchenne Muscular Dystrophy: lessons learned from a phase 3 trial.

Giovanni Baranello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39443734